PE20030725A1 - Compuestos hexaciclicos - Google Patents

Compuestos hexaciclicos

Info

Publication number
PE20030725A1
PE20030725A1 PE2002001148A PE2002001148A PE20030725A1 PE 20030725 A1 PE20030725 A1 PE 20030725A1 PE 2002001148 A PE2002001148 A PE 2002001148A PE 2002001148 A PE2002001148 A PE 2002001148A PE 20030725 A1 PE20030725 A1 PE 20030725A1
Authority
PE
Peru
Prior art keywords
alkyl
compounds
ethyl
hexaciclic
indolyzine
Prior art date
Application number
PE2002001148A
Other languages
English (en)
Spanish (es)
Inventor
Nobuo Shimma
Hitomi Suda
Masao Tsukazaki
Satoshi Niizuma
Takeshi Murata
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PE20030725A1 publication Critical patent/PE20030725A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PE2002001148A 2001-11-30 2002-11-28 Compuestos hexaciclicos PE20030725A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01128361 2001-11-30

Publications (1)

Publication Number Publication Date
PE20030725A1 true PE20030725A1 (es) 2003-08-28

Family

ID=8179394

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2002001148A PE20030725A1 (es) 2001-11-30 2002-11-28 Compuestos hexaciclicos

Country Status (28)

Country Link
US (2) US6825194B2 (enExample)
EP (1) EP1480984B9 (enExample)
JP (1) JP4305909B2 (enExample)
KR (1) KR100895746B1 (enExample)
CN (1) CN100338066C (enExample)
AT (1) ATE398131T1 (enExample)
AU (1) AU2002356720B2 (enExample)
BR (1) BR0214615A (enExample)
CA (1) CA2468824C (enExample)
DE (1) DE60227113D1 (enExample)
ES (1) ES2307830T3 (enExample)
GT (1) GT200200250A (enExample)
HU (1) HUP0500062A3 (enExample)
IL (1) IL162058A0 (enExample)
MX (1) MXPA04005185A (enExample)
MY (1) MY136138A (enExample)
NO (1) NO329005B1 (enExample)
NZ (1) NZ533568A (enExample)
PA (1) PA8558901A1 (enExample)
PE (1) PE20030725A1 (enExample)
PL (1) PL207510B1 (enExample)
RS (1) RS51051B (enExample)
RU (1) RU2299212C2 (enExample)
TW (1) TWI258481B (enExample)
UA (1) UA80409C2 (enExample)
UY (1) UY27560A1 (enExample)
WO (1) WO2003045952A2 (enExample)
ZA (1) ZA200404522B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004073601A2 (en) * 2003-02-21 2004-09-02 Chugai Seiyaku Kabushiki Kaisha Process for the preparation of hexacyclic camptothecin derivatives
US7910593B2 (en) 2004-04-09 2011-03-22 Chugai Seiyaku Kabushiki Kaisha Water-soluble prodrugs
TW200744603A (en) 2005-08-22 2007-12-16 Chugai Pharmaceutical Co Ltd Novel anticancer concomitant drug
US20090118271A1 (en) * 2005-10-19 2009-05-07 Chugai Seiyaku Kabushiki Kaisha Preventive or Therapeutic Agents for Pancreatic Cancer, Ovarian Cancer, or Liver Cancer Comprising a Novel Water-Soluble Prodrug
RU2439073C1 (ru) * 2010-07-13 2012-01-10 Государственное образовательное учреждение высшего профессионального образования "Кубанский государственный технологический университет" (ГОУ ВПО "КубГТУ") СПОСОБ ПОЛУЧЕНИЯ ПРОИЗВОДНЫХ ИНДОЛИЗИНО[7,6-b]ИНДОЛА
KR20240104214A (ko) 2019-03-29 2024-07-04 메디뮨 리미티드 화합물 및 이의 접합체

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4473692A (en) 1981-09-04 1984-09-25 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives and process for preparing same
US4939255A (en) * 1987-06-24 1990-07-03 Daiichi Pharmaceutical Co., Ltd. Hexa-cyclic camptothecin derivatives
HU213136B (en) * 1990-08-14 1997-02-28 Kyorin Seiyaku Kk Process for producing fluoroethyl camptothecin derivatives and pharmaceutical compositions containing them
JP3008226B2 (ja) * 1991-01-16 2000-02-14 第一製薬株式会社 六環性化合物
JP3359955B2 (ja) * 1992-07-16 2002-12-24 第一製薬株式会社 抗腫瘍剤
GB9402934D0 (en) * 1994-02-16 1994-04-06 Erba Carlo Spa Camptothecin derivatives and process for their preparation
US5663177A (en) * 1995-05-31 1997-09-02 Smithkline Beecham Corporation Water soluble camptothecin analogs
DE69834923T2 (de) 1997-02-14 2006-10-19 Bionumerik Pharmaceuticals, Inc., San Antonio Hochgradig lipophile camptothecin-derivate
GB9715821D0 (en) * 1997-07-25 1997-10-01 Pharmacia & Upjohn Spa Amidino-camptothecin derivatives

Also Published As

Publication number Publication date
KR100895746B1 (ko) 2009-04-30
MXPA04005185A (es) 2004-08-11
PL370479A1 (en) 2005-05-30
AU2002356720A1 (en) 2003-06-10
RU2004119841A (ru) 2005-03-27
ATE398131T1 (de) 2008-07-15
HUP0500062A3 (en) 2012-12-28
IL162058A0 (en) 2005-11-20
PA8558901A1 (es) 2003-06-30
NO20042729L (no) 2004-08-27
US6825194B2 (en) 2004-11-30
EP1480984B9 (en) 2009-03-11
RU2299212C2 (ru) 2007-05-20
JP2005511643A (ja) 2005-04-28
HK1077303A1 (en) 2006-02-10
TWI258481B (en) 2006-07-21
UY27560A1 (es) 2003-05-30
US20030144304A1 (en) 2003-07-31
ZA200404522B (en) 2005-01-04
MY136138A (en) 2008-08-29
CN100338066C (zh) 2007-09-19
NO329005B1 (no) 2010-07-19
UA80409C2 (en) 2007-09-25
WO2003045952A3 (en) 2003-10-16
GT200200250A (es) 2004-01-15
PL207510B1 (pl) 2010-12-31
AU2002356720B2 (en) 2009-01-29
US20050059679A1 (en) 2005-03-17
ES2307830T3 (es) 2008-12-01
RS47004A (sr) 2007-02-05
TW200408642A (en) 2004-06-01
DE60227113D1 (de) 2008-07-24
CA2468824C (en) 2011-01-11
JP4305909B2 (ja) 2009-07-29
WO2003045952A2 (en) 2003-06-05
RS51051B (sr) 2010-10-31
KR20040062976A (ko) 2004-07-09
US7109195B2 (en) 2006-09-19
HUP0500062A2 (hu) 2005-04-28
EP1480984B1 (en) 2008-06-11
BR0214615A (pt) 2004-09-14
CN1617874A (zh) 2005-05-18
CA2468824A1 (en) 2003-06-05
HK1072935A1 (en) 2005-09-16
NZ533568A (en) 2006-01-27
EP1480984A2 (en) 2004-12-01

Similar Documents

Publication Publication Date Title
PE20030258A1 (es) Derivados de dolastatina con actividad antitumoral
DK1412354T3 (da) Derivater af triazolylimidazopyridin og af triazolylpurinerne, der er egnede som ligander for adenosin A2a?-receptoren og deres anvendelse som medikamenter
GEP20084357B (en) Pyrimidine derivatives for the treatment of abnormal cell growth
NO20062713L (no) 2,6 bisheteroaryl-4-aminopyrimidiner som adenosin reseptor antagonister
AR034448A1 (es) Uso de derivados de nucleosidos, dichos derivados de nucleosidos para dicho uso, composiciones farmaceuticas que los comprenden y uso de dichas composiciones
UY27978A1 (es) Nuevos compuestos de oxazol y tiazol como inhibidores del factor de crecimiento transformador (tgf)
HUP0203870A2 (hu) Adenozinreceptor agonistát vagy antagonistát tartalmazó gyógyászati készítmény
CO5180642A1 (es) Compuestos sustituidos de piperidina, procesos para su prepa racion, composiciones farmaceuticas que los contienen y su utilizacion
AR036906A1 (es) Compuestos de imidazopiridin como moduladores del receptor 5-ht4
BR0010476A (pt) Compostos derivados do 4,5,6,7-tetrahidroindazol e seu uso como agentes antitumorais
MY138352A (en) Benzothiazole derivatives
GEP20094723B (en) Tetraazabenzo [e] azulene derivatives and analogs thereof
NO20021328L (no) Pyrazolopyrimidier som terapeutiske midler
BR0317294A (pt) Composto, formulação farmacêutica, uso de um composto, métodos de prevenção e/ou tratamento de condições associadas com a glicogênio sintase quinase-3 e de prevenção e/ou tratamento de doenças, e, uso dos intermediários
NO20033145D0 (no) Purinderivater som purinergiske reseptorantagonister
PE20050420A1 (es) Fenacilo 2-hidroxi-3-diaminoalcanos
DE60001586D1 (de) Diphenyl-piperidin derivate
EA200400007A1 (ru) ФАРМАЦЕВТИЧЕСКИЙ СОСТАВ ДЛЯ ЭФФЕКТИВНОГО ВВЕДЕНИЯ АПОМОРФИНА, 6aR-(-)-N-ПРОПИЛ-НОРАПОМОРФИНА, ИХ ПРОИЗВОДНЫХ И ИХ ПРОЛЕКАРСТВ
AR013079A1 (es) Derivados sustituidos de tetrahidrofurano-3-onas, de tetrahidropirano-3- onas y tetrahidrotiofen-3-onas, un procedimiento para su preparacion unacomposicion farmaceutica de un medicamento util como inhibidores de proteasas e intermediarios
AR008177A1 (es) Nuevas bisindolilmaleimidas, sales de las mismas, procesos para su preparacion intermediarios, su uso para la fabricacion de medicamentos, metodode tratamiento y composicion farmaceutica.
SE9702563D0 (sv) Compounds
NO20062491L (no) Benzoksazinderivter og deres anvendelse
NO20061981L (no) Arylindenopyridiner og arylindenopyridiner og deres anvendelse som adenosin A2A reseptoragonist
NO20052229L (no) Basiske estere av fettalkoholer og deres anvendelse som antiinfammatoriske eller immunstimulerende midler
BR0312175A (pt) Composto, composição farmacêutica, uso de um composto, método para o tratamento e método para reduzir a morbidez e a mortalidade associadas com o excesso de peso

Legal Events

Date Code Title Description
FA Abandonment or withdrawal